
    
      Primary Outcome Measure(s) To demonstrate a clinically significant difference between the
      patients treated with adjuvants and those patients randomized to Group I in the pain status,
      physical, and psychological status and pain at 3, 6, 12, 18and 24 months post treatment.
    
  